Lung cancer screening: Current status and perspective

Lung cancer screening: current situation and perspective.

Worldwide, lung cancer is the most common cancer in terms of both incidence and mortality with 1,04 million new cases per year and 921,000 deaths, with the highest rates currently observed in Europe and North America. Once diagnosed, the 5-year survival rate for lung cancer in Europe fluctuates between 8% and 12%. Smoking is found in 90% of lung cancer cases. A successful, straightforward preve...

Lung Cancer Screening: Current Status in the United States

[Breast cancer screening: current status].

The currently available scientific evidence attests that mammographic screening and quality treatment have been able to reduce mortality attributable to breast cancer. Although screening is not without risks, population-based screening has clear advantages over opportunistic detection. Following the Council of the European Union's "Recommendations on cancer screening", all the regional Autonomo...

Breast cancer screening: Current status

Lung Cancer Staging—Current Status and Controversies

Lung cancer is the leading cause of cancer-related mortality in the US. Over 215,000 cases are expected to be diagnosed in 2008, with over 161,000 deaths per year. Appropriate therapy is dependent on accurate staging to determine those amenable to surgery and define the appropriate role for chemotherapy and radiation therapy. For many years, the tumor, node, metastases (TNM) classification syst...